Víctor A Arrieta

5PUBLICATIONS
43CO-AUTHORS
NanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 11, 2025
Pharmacokinetic Analysis of Carboplatin and Fluorescein Brain Retention following Ultrasound-Based Blood-Brain Barrier Opening.

Karl J Habashy, Timothy W Synold, Ye Feng

|Jan 31, 2024
Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for Glioblastoma.

Karl J Habashy, Crismita Dmello, Li Chen

|Nov 08, 2023
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis.

Víctor A Arrieta, Johnny Duerinck, Kirsten B Burdett

|May 13, 2022
Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma.

Crismita Dmello, Aarón Sonabend, Victor A Arrieta

|Dec 24, 2021
The Eclectic Nature of Glioma-Infiltrating Macrophages and Microglia.

Víctor A Arrieta, Hinda Najem, Edgar Petrosyan

Pageof 1

Frequent Collaborators

4 joint publications

Crismita Dmello

4 joint publications

Adam M Sonabend

4 joint publications

Roger Stupp

3 joint publications

Karl J Habashy